ARCHIVES

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999